Leveraging In Vivo Models to Support ADC Preclinical Safety Characterization & Translation to the Clinic
- Exploring preclinical toxicity characterization across different ADC payload classes
- Selecting and utilizing optimal in vivo models to best replicate clinical toxicity profiles
- Measuring predictability of different in vivo models from ADC translational data